Verena Jendrossek

7.9k total citations
160 papers, 6.3k citations indexed

About

Verena Jendrossek is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Verena Jendrossek has authored 160 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Molecular Biology, 39 papers in Oncology and 29 papers in Cancer Research. Recurrent topics in Verena Jendrossek's work include Cell death mechanisms and regulation (27 papers), Cancer, Hypoxia, and Metabolism (19 papers) and PI3K/AKT/mTOR signaling in cancer (12 papers). Verena Jendrossek is often cited by papers focused on Cell death mechanisms and regulation (27 papers), Cancer, Hypoxia, and Metabolism (19 papers) and PI3K/AKT/mTOR signaling in cancer (12 papers). Verena Jendrossek collaborates with scholars based in Germany, United States and Switzerland. Verena Jendrossek's co-authors include Claus Belka, Erich Gulbins, Heike Grassmé, Florian Wirsdörfer, René Handrick, Diana Klein, Andrea Riehle, Justine Rudner, Wilfried Budach and Simone de Leve and has published in prestigious journals such as The Lancet, Angewandte Chemie International Edition and Nature Medicine.

In The Last Decade

Verena Jendrossek

157 papers receiving 6.2k citations

Peers

Countries citing papers authored by Verena Jendrossek

Since Specialization

Citations

This map shows the geographic impact of Verena Jendrossek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Verena Jendrossek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Verena Jendrossek more than expected).

Fields of papers citing papers by Verena Jendrossek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Verena Jendrossek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Verena Jendrossek. The network helps show where Verena Jendrossek may publish in the future.

Co-authorship network of co-authors of Verena Jendrossek

This figure shows the co-authorship network connecting the top 25 collaborators of Verena Jendrossek. A scholar is included among the top collaborators of Verena Jendrossek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Verena Jendrossek. Verena Jendrossek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CD73/adenosine dynamics in treatment-induced pneumonitis: balancing efficacy with risks of adverse events in combined radio-immunotherapies 2025 ·Frontiers in Cell and Developmental Biology ·(unknown), Florian Wirsdörfer, Verena Jendrossek	3
2	Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment—Comparison with Stage III Disease 2024 ·Cancers ·Maja Guberina, Christoph Pöttgen, Nika Guberina, (unknown), Marcel Wiesweg, (unknown), Martin Metzenmacher, Clemens Aigner, Servet Bölükbas, Thomas Gauler, Wilfried Eberhardt, Michael Forsting, Ken Herrmann, Dirk Theegarten, Kaid Darwiche, Verena Jendrossek, Martin Stuschke, Martin Schüler	3
3	Combined radiation- and immune checkpoint-inhibitor-induced pneumonitis – The challenge to predict and detect overlapping immune-related adverse effects from evolving laboratory biomarkers and clinical imaging 2023 ·Neoplasia ·Nika Guberina, Florian Wirsdörfer, Martin Stuschke, Verena Jendrossek	8
4	Metformin Protects against Radiation-Induced Acute Effects by Limiting Senescence of Bronchial-Epithelial Cells 2021 ·International Journal of Molecular Sciences ·(unknown), Samantha Barr, (unknown), Kirsten Lauber, Julia Heß, Kristian Unger, Horst Zitzelsberger, Verena Jendrossek, Diana Klein	26
5	Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven radioresistence and improves radiotherapy 2021 ·Cell Death and Disease ·(unknown), (unknown), Diana Klein, Verena Jendrossek, Justine Rudner	37
6	Early senescence and production of senescence-associated cytokines are major determinants of radioresistance in head-and-neck squamous cell carcinoma 2021 ·Cell Death and Disease ·Ulrike Schoetz, Diana Klein, Julia Heß, (unknown), Steffen Spoerl, Michael Orth, (unknown), Roman Hennel, Anja Sieber, Ute Ganswindt, Benedikt Luka, Andreas Thomsen, Kristian Unger, Verena Jendrossek, Horst Zitzelsberger, Nils Blüthgen, Claus Belka, Steffen Unkel, Bertram Klinger, Kirsten Lauber	46
7	Activation of anti-oxidant Keap1/Nrf2 pathway modulates efficacy of dihydroartemisinin-based monotherapy and combinatory therapy with ionizing radiation 2021 ·Free Radical Biology and Medicine ·(unknown), (unknown), (unknown), Verena Jendrossek, Justine Rudner	24
8	Adaptation to Chronic-Cycling Hypoxia Renders Cancer Cells Resistant to MTH1-Inhibitor Treatment Which Can Be Counteracted by Glutathione Depletion 2021 ·Cells ·(unknown), (unknown), (unknown), (unknown), Jüergen Thomale, Thomas Helleday, Verena Jendrossek, Johann Matschke	10
9	Loss of pro-apoptotic Bax and Bak increases resistance to dihydroartemisinin-mediated cytotoxicity in normoxia but not in hypoxia in HCT116 colorectal cancer cells 2021 ·Free Radical Biology and Medicine ·(unknown), (unknown), (unknown), (unknown), Verena Jendrossek, Justine Rudner	5
10	Cellular Senescence in the Lung: The Central Role of Senescent Epithelial Cells 2020 ·International Journal of Molecular Sciences ·(unknown), Verena Jendrossek, Diana Klein	58
11	Caveolin-1 regulates the ASMase/ceramide-mediated radiation response of endothelial cells in the context of tumor–stroma interactions 2020 ·Cell Death and Disease ·(unknown), (unknown), (unknown), (unknown), (unknown), Patrick Maier, Henning Reis, Carsten Herskind, Verena Jendrossek, François Paris, Diana Klein	35
12	High-throughput Evaluation of Protein Migration and Localization after Laser Micro-Irradiation 2019 ·Scientific Reports ·Sebastian Oeck, Nathalie M. Malewicz, (unknown), Audrey Turchick, Verena Jendrossek, Peter M. Glazer	11
13	Progression-Related Loss of Stromal Caveolin 1 Levels Mediates Radiation Resistance in Prostate Carcinoma via the Apoptosis Inhibitor TRIAP1 2019 ·Journal of Clinical Medicine ·(unknown), Andrej Panic, Henning Reis, (unknown), Patrick Maier, Carsten Herskind, Ernesto Yagüe, Verena Jendrossek, Diana Klein	25
14	Mesenchymal Stem Cell Therapy Protects Lungs from Radiation-Induced Endothelial Cell Loss by Restoring Superoxide Dismutase 1 Expression 2016 ·Antioxidants and Redox Signaling ·Diana Klein, (unknown), (unknown), Florian Schulz, Farnusch Kaschani, Katharina Röck, Masahiro Yamaguchi, Florian Wirsdörfer, Markus Kaiser, Jens W. Fischer, Martin Stuschke, Verena Jendrossek	82
15	Targeted Inhibition of Glutamine-Dependent Glutathione Metabolism Overcomes Death Resistance Induced by Chronic Cycling Hypoxia 2016 ·Antioxidants and Redox Signaling ·Johann Matschke, (unknown), Diana Klein, René Handrick, Lutz Lüdemann, Eric Metzen, Tomer Shlomi, Martin Stuschke, Verena Jendrossek	49
16	Deubiquitylating enzyme USP9x regulates radiosensitivity in glioblastoma cells by Mcl-1-dependent and -independent mechanisms 2016 ·Cell Death and Disease ·(unknown), (unknown), Jens Schittenhelm, Tsambika Psaras, (unknown), Laura Bornes, Stephan M. Huber, Verena Jendrossek, Justine Rudner	34
17	Dihydroartemisinin Induces Apoptosis by a Bak-Dependent Intrinsic Pathway 2010 ·Molecular Cancer Therapeutics ·René Handrick, (unknown), (unknown), (unknown), (unknown), Jan Dürig, Claus Belka, Verena Jendrossek	77
18	High activity of acid sphingomyelinase in major depression 2005 ·Journal of Neural Transmission ·Johannes Kornhuber, (unknown), Stefan Bleich, Verena Jendrossek, Andreas Henkel, Jens Wiltfang, Erich Gulbins	120
19	Novel chemotherapeutic agents for the treatment of glioblastoma multiforme 2003 ·Expert Opinion on Investigational Drugs ·Verena Jendrossek, Claus Belka, Michael Bamberg	36
20	Ceramide-Rich Membrane Rafts Mediate CD40 Clustering 2002 ·The Journal of Immunology ·Heike Grassmé, Verena Jendrossek, Jürgen Bock, Andrea Riehle, Erich Gulbins	225

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact